We are live on ! Find out more
AP

AHL Partners Portfolio holdings

AUM $6.41B
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$662M
Cap. Flow
+$649M
Cap. Flow %
50.25%
Top 10 Hldgs %
4.83%
Holding
826
New
152
Increased
400
Reduced
144
Closed
124

Sector Composition

1 Technology 26.28%
2 Healthcare 19.57%
3 Consumer Staples 12.38%
4 Financials 11.89%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMH
151
DELISTED
Team Health Holdings Inc
TMH
$2.99M 0.23%
+68,119
New +$3.61M
JNJ icon
152
Johnson & Johnson
JNJ
$609B
$2.96M 0.23%
28,857
+21,872
+313% +$2.2M
ADEA icon
153
Adeia
ADEA
$2.8B
$2.96M 0.23%
373,233
+304,959
+447% +$2.67M
GILD icon
154
Gilead Sciences
GILD
$167B
$2.96M 0.23%
29,249
+22,756
+350% +$2.37M
CPAY icon
155
Corpay
CPAY
$23.9B
$2.94M 0.23%
+20,600
New +$3.03M
TARO
156
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.9M 0.22%
18,793
+15,189
+421% +$2.22M
AMGN icon
157
Amgen
AMGN
$198B
$2.9M 0.22%
17,833
+13,657
+327% +$2.15M
XLNX
158
DELISTED
Xilinx Inc
XLNX
$2.88M 0.22%
61,385
+50,709
+475% +$2.4M
MRVL icon
159
Marvell Technology
MRVL
$169B
$2.87M 0.22%
324,973
+266,858
+459% +$2.36M
A icon
160
Agilent Technologies
A
$37.1B
$2.82M 0.22%
67,520
+57,995
+609% +$2.24M
TXN icon
161
Texas Instruments
TXN
$258B
$2.82M 0.22%
51,500
+42,113
+449% +$2.35M
MRK icon
162
Merck
MRK
$315B
$2.82M 0.22%
55,889
+41,978
+302% +$2.12M
PBH icon
163
Prestige Consumer Healthcare
PBH
$2.36B
$2.81M 0.22%
54,520
+44,576
+448% +$2.21M
MXIM
164
DELISTED
Maxim Integrated Products
MXIM
$2.8M 0.22%
73,699
+61,922
+526% +$2.37M
INTC icon
165
Intel
INTC
$478B
$2.79M 0.22%
80,965
+64,676
+397% +$2.19M
QGENF
166
DELISTED
QIAGEN NV
QGENF
$2.78M 0.22%
100,427
+83,894
+507% +$2.32M
WAT icon
167
Waters Corp
WAT
$36.2B
$2.78M 0.21%
20,628
+16,325
+379% +$2.1M
MCHP icon
168
Microchip Technology
MCHP
$44B
$2.76M 0.21%
+118,530
New +$2.78M
IQV icon
169
IQVIA
IQV
$34.4B
$2.75M 0.21%
40,101
+33,357
+495% +$2.28M
CLX icon
170
Clorox
CLX
$11.6B
$2.75M 0.21%
21,693
+17,338
+398% +$2.15M
MELI icon
171
Mercado Libre
MELI
$92B
$2.75M 0.21%
24,051
+18,017
+299% +$1.98M
SYNH
172
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.73M 0.21%
56,221
+44,276
+371% +$1.97M
TMO icon
173
Thermo Fisher Scientific
TMO
$198B
$2.72M 0.21%
19,201
+15,578
+430% +$2.08M
UNM icon
174
Unum
UNM
$14.2B
$2.7M 0.21%
80,989
+22,791
+39% +$786K
MTD icon
175
Mettler-Toledo International
MTD
$26.5B
$2.67M 0.21%
7,861
+6,253
+389% +$2.01M

Similar funds

AHL Partners's Q4 2015 Portfolio in Review

As of Q4 2015, AHL Partners held 826 positions worth $1.29B, up 105% from $630M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

AHL Partners deployed $649M of net new capital in Q4 2015, opening 152 new positions and adding to 400 existing holdings. Its largest new stake was Vanguard Real Estate ETF: 85,725 shares worth $6.83M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Coca-Cola, an estimated $4.45M trimmed.

  • AHL Partners's largest Q4 2015 buy was Vanguard Real Estate ETF: 85,725 shares worth $6.83M.
  • AHL Partners added most to Mentor Graphics Corp in Q4 2015, an estimated $6.06M increase.
  • AHL Partners's biggest Q4 2015 reduction was Coca-Cola, cutting an estimated $4.45M.
  • AHL Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2015, selling an estimated $5.71M.
  • AHL Partners's ten largest holdings make up 4.8% of its $1.29B portfolio in Q4 2015.
  • AHL Partners opened 152 new positions and closed 124 in Q4 2015.
  • AHL Partners's portfolio value rose 105% quarter-over-quarter to $1.29B.

Based on AHL Partners's 13F filing for Q4 2015, filed 16 Feb 2016.